TYROSINKINASE-HEMMER

European patent · EP2710005 · In force

Register entry

Publication number
EP2710005
Application number
EP12722662
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 16, 2012
Published
Mar 26, 2014
Granted
Oct 5, 2016
Protection ends at the latest
May 15, 2032
Next annual fee due
May 31, 2027
IPC classes
A61K 45/06 (2006.01)
A61K 31/519 (2006.01)
A61K 31/5377 (2006.01)
C07D 487/04 (2006.01)
Priority
US 201161486944 P 17.05.2011
US 201161514892 P 03.08.2011
US 201161556336 P 07.11.2011
US 201261618152 P 30.03.2012
PCT application
PCT/US2012/038092 16.05.2012
PCT publication
WO2012/158764 22.11.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Mar 28, 2025

    Agent removed

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)

    Published in Swissreg on 28.03.2025

  4. Mar 28, 2025

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 28.03.2025

  5. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  6. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  7. Jan 6, 2017

    Agent entered

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern

    Published in Swissreg on 06.01.2017

  8. Oct 5, 2016

    Granted

    Published in Swissreg on 05.10.2016

Parties

Inventor

GOLDSTEIN, David Michael

Redwood City California 94061, US

BRAMELD, Kenneth Albert

Menlo Park California 94027, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.